It was also reported that ATLIII inhibits mast cell proliferation, upregulates anti-inflammatory cytokines (Yoou et al., 2017), and inhibits pro-inflammatory cytokines such as IL-6, IL-8, IL-1β, and TNF-α in tumor microenvironment. This evidence concerns the gene CXCL8 and neoplasm.